c-myc can act on SLC7A11 to promote glutamine excretion, in exchange for an increase in intracellular cysteine, which in turn was used for glutathione synthesis, thus protecting tumor cells from oxidative damage [85, 88]. The gene discussed is MYC; the disease is neoplasm.